WuXi Apptec WKN: A2PAJG ISIN: CNE100003F19 Kürzel: WX8 Forum: Aktien User: Summer.76

WuXi Biologics ... and WuXi STA, a subsidiary of WuXi AppTec, today announced that a joint venture company named WuXi XDC was established to provide end-to-end contract development and manufacturing of bioconjugates including antibody-drug conjugates (ADCs). Dr. Jimmy (Jincai) Li was appointed as CEO of WuXi XDC. https://www.prnewswire.com/news-releases/wuxi-biologics-and-wuxi-sta-jointly-established-wuxi-xdc-to-provide-fully-integrated-bioconjugate-cdmo-services-301291101.html

Ein Fall für den Übersetzer, etwas ausführlicher und mit Ratings zur AppTec sowie weiteren Werten: Zhitong Daily Dahang Research Report丨 WuXi AppTec (02359) first quarter results better than expected growth momentum or will continue https://m.jrj.com.cn/madapter/hk/2021/05/03171332596272.shtml

https://www.finanzen.net/nachricht/aktien/wuxi-apptec-quartalsergebnisse-zum-juengsten-jahresviertel-10080234

https://static.wuxiapptec.com/9d/20210429/9df0fd07ddf8ec8c.pdf WuXi AppTec First Quarter 2021 Earnings Presentation

WuXi AppTec Reports Record First-Quarter 2021 Results https://www.prnewswire.com/news-releases/wuxi-apptec-reports-record-first-quarter-2021-results-301279988.html Revenue Up 55.3% Year-Over-Year to RMB4.95 Billion Net Profit Attributable to Owners of the Company Up 394.9% Year-over-Year to RMB1.50 Billion Diluted EPS Up 369.2% Year-Over-Year to RMB0.61 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 63.6% Year-Over-Year to RMB943 Million Adjusted Diluted Non-IFRS EPS Up 52.0% Year-Over-Year to RMB0.38 ...

WuXi AppTec (02359): Ungefähr 3,3462 Millionen Restricted Stocks werden von Verkaufsbeschränkungen befreit https://m.jrj.com.cn/madapter/hk/2021/04/28232632474990.shtml

G Sachs: CN Drug R&D Outsourcing Sector Profit Outlook Solid; Top-picks Wuxi Series of Co. http://www.aastocks.com/en/stocks/analysis/stock-aafn-con/02359/NOW.1092723/hk-stock-news

G Sachs' Latest Ratings & TPs on CN Drug Developers/ Agents  http://www.aastocks.com/en/stocks/analysis/stock-aafn-con/02359/NOW.1092720/hk-stock-news Stocks｜Ratings｜TPs (HK$) WUXI APPTEC   Buy 200.5→202.3

Morgan Stanley: Upgrading WuXi AppTec's (02359) target price to HK$187, rating "overweight" https://m.jrj.com.cn/madapter/hk/2021/04/15102132377985.shtml Morgan Stanley released a research report that raised the target price of WuXi AppTec (02359) from HK$178 to HK$187, with a rating of “overweight”. According to the report, taking into account the company’s performance in the second half of last year and the rapid recovery of production orders in various regions, it raised its 2021-24 profit forecast by about 8% to 9%, and raised the company’s capital expenditure forecast. , WuXi AppTec's production demand will greatly increase.

https://www.businesswire.com/news/home/20210407005162/en/Endevica-Bio-Begins-IND-Enabling-Toxicology-Studies

Etwas länger und ein Fall für den Übersetzer: Die Leistung von WuXi AppTec im Jahr 2020 steigt um fast 60%, die Bestellungen steigen weiter, das Kapital steigt weiter https://wap.stockstar.com/detail/IG2021040100000703

Das klingt doch alles ganz gut

WuXi AppTec (02359 HK) proposes to issue a final dividend of 36.3 cents for every 10 shares to increase by 2 shares https://www.finet.hk/newscenter/news_content/60638ecfbde0b335eab748ee WuXi AppTec (02359 HK) announced its annual results for the year ended December 31, 2020. During the period, revenue was 16.535 billion yuan (RMB. The same below), an increase of 28.46%; profit was 2.96 billion yuan, Year-on-year increase of 59.62%, earnings per share of 1.27 yuan; a final dividend of 36.3 cents per share is recommended, and 2 shares for every 10 shares.   ... FINAL DIVIDEND AND CONVERSION OF RESERVE TO SHARE CAPITAL The Board proposes the profit distribution plan for the year ended December 31, 2020 as follows: (i) a cash dividend of RMB3.63 (inclusive of tax) for every 10 shares (representing an aggregate amount of RMB889,537,206.36 (inclusive of tax) based on the total issued share capital of the Company as of the date of this announcement), and (ii) 2 new Shares for every 10 existing Shares of the Company to be issued out of reserve to all Shareholders.  ...

https://www.finanzen.net/nachricht/aktien/wuxi-apptec-bilanzvorlage-zum-letzten-quartal-9970658

WuXi AppTec Reports Strong 2020 Annual Results https://www.prnewswire.com/news-releases/wuxi-apptec-reports-strong-2020-annual-results-301258546.html Revenue Up 28.5% Year-over-Year to RMB16,535 Million Net Profit Attributable to Owners of the Company Up 59.6% Year-over-Year to RMB2,960 Million Diluted EPS Up 56.3% Year-over-Year to RMB1.25 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 48.1% Year-over-Year to RMB3,565 Million Adjusted Diluted Non-IFRS EPS Up 45.2% Year-over-Year to RMB1.51